Year archive

NeuroThera Labs Inc. — 2021 filings

All 21 regulatory filings released by NeuroThera Labs Inc. (NTLX) in 2021, sourced directly from the official regulator.

21 Filings

2021 Period

2021 filings (21)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-12-21	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2021-12-21	English
Interim MD&A - English.pdf Interim / Quarterly Report	2021-12-21	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2021-12-20	English
Material change report - English.pdf Board/Management Information	2021-07-20	English
News release - English.pdf Capital/Financing Update	2021-07-20	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-07-05	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2021-07-05	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2021-07-05	English
Other material contract(s).pdf Governance Information	2021-06-09	English
Auditors' consent letter.pdf Regulatory Filings	2021-06-09	English
Final prospectus – English.pdf Regulatory Filings	2021-06-09	English
Escrow agreement.pdf Regulatory Filings	2021-06-09	English
Underwriting or agency agreement.pdf Regulatory Filings	2021-06-09	English
Consent letter(s) of issuer's legal counsel.pdf Regulatory Filings	2021-06-09	English
Decision Document (Preliminary).pdf Regulatory Filings	2021-04-15	English
Preliminary prospectus – English.pdf Capital/Financing Update	2021-04-15	English
Material contracts.pdf Share Issue/Capital Change	2021-04-15	English
Material contracts.pdf Regulatory Filings	2021-04-15	English
Material contracts.pdf Share Issue/Capital Change	2021-04-15	English
Material contracts.pdf Share Issue/Capital Change	2021-04-15	English